Elele Ezinwa, Shen Yueyang, Boppana Rajyalakshmi, Afolabi Afolawemi, Bilgili Ecevit, Khusid Boris
Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Pharmaceutics. 2020 Oct 29;12(11):1034. doi: 10.3390/pharmaceutics12111034.
We demonstrate the ability to fabricate dosage forms of a poorly water-soluble drug by using wet stirred media milling of a drug powder to produce an aqueous suspension of nanoparticles and then print it onto a porous biocompatible film. Contrary to conventional printing technologies, a deposited material is pulled out from the nozzle. This feature enables printing highly viscous materials with a precise control over the printed volume. Drug (griseofulvin) nanosuspensions prepared by wet media milling were printed onto porous hydroxypropyl methylcellulose films prepared by freeze-drying. The drug particles retained crystallinity and polymorphic form in the course of milling and printing. The versatility of this technique was demonstrated by printing the same amount of nanoparticles onto a film with droplets of different sizes. The mean drug content (0.19-3.80 mg) in the printed films was predicted by the number of droplets (5-100) and droplet volume (0.2-1.0 µL) ( = 0.9994, -value < 10). Our results also suggest that for any targeted drug content, the number-volume of droplets could be modulated to achieve acceptable drug content uniformity. Analysis of the model-independent difference and similarity factors showed consistency of drug release profiles from films with a printed suspension. Zero-order kinetics described the griseofulvin release rate from 1.8% up to 82%. Overall, this study has successfully demonstrated that the electro-hydrodynamic drop-on-demand printing of an aqueous drug nanosuspension enables accurate and controllable drug dosing in porous polymer films, which exhibited acceptable content uniformity and reproducible drug release.
我们展示了通过对难溶性药物粉末进行湿式搅拌介质研磨以制备纳米颗粒水悬浮液,然后将其打印到多孔生物相容性薄膜上来制造剂型的能力。与传统印刷技术相反,沉积材料是从喷嘴中被拉出的。这一特性使得能够精确控制打印体积来打印高粘性材料。通过湿式介质研磨制备的药物(灰黄霉素)纳米悬浮液被打印到通过冷冻干燥制备的多孔羟丙基甲基纤维素薄膜上。药物颗粒在研磨和打印过程中保持结晶度和多晶型形式。通过将相同量的纳米颗粒打印到具有不同尺寸液滴的薄膜上,证明了该技术的多功能性。打印薄膜中的平均药物含量(0.19 - 3.80毫克)可通过液滴数量(5 - 100个)和液滴体积(0.2 - 1.0微升)进行预测( = 0.9994, -值 < 10)。我们的结果还表明,对于任何目标药物含量,液滴的数量 - 体积可以进行调节以实现可接受的药物含量均匀性。对与模型无关的差异和相似性因素的分析表明,含有打印悬浮液的薄膜的药物释放曲线具有一致性。零级动力学描述了灰黄霉素从1.8%到82%的释放速率。总体而言,本研究成功证明了水性药物纳米悬浮液的电动流体按需滴印能够在多孔聚合物薄膜中实现准确且可控的药物给药,该薄膜表现出可接受的含量均匀性和可重复的药物释放。